Genome & Company (KOSDAQ:314130)

Genome & Company Revenue

Genome & Company had revenue of 6.25B KRW in the quarter ending June 30, 2026, with 7.66% growth. This brings the company's total for the last twelve months to 24.46B, up 1.84% year-over-year. In the year 2025, Genome & Company had annual revenue of 24.59B, down -11.38%. That makes Genome & Company the 34,259th largest company in the world by revenue and 2,189th in South Korea.

• Revenue (ttm): 24.46B
• Revenue Growth: +1.84%
• P/S Ratio: 8.58
• Revenue / Employee: 254.80M
• Employees: 96
• Market Cap: 209.98B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• South Korea 13.37B 54.4%
• Asia 5.95B 24.2%
• North America 4.44B 18.0%
• Europe 785.01M 3.2%
• South America 31.13M 0.1%
• Oceania 13.71M 0.1%

Fiscal year ended Dec 31, 2025 See the full Genome & Company breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	24.59B	-3.16B	-11.38%
Dec 31, 2024	27.74B	13.45B	94.07%
Dec 31, 2023	14.30B	211.39M	1.50%
Dec 31, 2022	14.08B	13.63B	3,021.27%
Dec 31, 2021	451.25M	300.66M	199.67%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 22, 2026

Data Sources Report a data error